Brief: Xspray Pharma Approved For Listing On Nasdaq Stockholm
March 18 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY PHARMA APPROVED FOR LISTING ON NASDAQ STOCKHOLM
* TRADING OF COMPANY'S SHARES ON NASDAQ STOCKHOLM'S MAIN
MARKET IS
EXPECTED TO COMMENCE ON FRIDAY 27 MARCH 2020, AND LAST DAY OF
TRADING ON NASDAQ FIRST NORTH GROWTH MARKET IS EXPECTED TO BE
THURSDAY 26 MARCH
Source text for Eikon: ID:nWkr30tLz2
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003